Inhibition of tumorigenicity in lung adenocarcinoma cells by c-erbB-2 antisense expression
Open Access
- 7 August 1997
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 72 (4) , 631-636
- https://doi.org/10.1002/(sici)1097-0215(19970807)72:4<631::aid-ijc14>3.0.co;2-e
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Control of oncogene expression by antisense nucleic acidsEuropean Journal Of Cancer, 1994
- erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplificationBritish Journal of Cancer, 1994
- Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene.Proceedings of the National Academy of Sciences, 1994
- Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.Journal of Clinical Oncology, 1992
- p185 HER2/neu Epitope Mapping with Murine Monoclonal AntibodiesHybridoma, 1992
- A phase I/II study of trichosanthin treatment of HIV diseaseAIDS, 1990
- Effect of Antisense c- raf -1 on Tumorigenicity and Radiation Sensitivity of a Human Squamous CarcinomaScience, 1989
- erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 CellsScience, 1987
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985
- Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed.Molecular and Cellular Biology, 1983